Rockwell Medical Provides First Quarter 2022 Financial and O

- First quarter net sales of $16.1 million, up 4.2% year-over-year - - Submitted Supplemental Data to FDA for IND Application to enable Phase 2 FPC Home...

Related Keywords

China , United States , South Korea , Jeil , Kyonggi Do , Republic Of Korea , Russell Ellison , Davita Inc , Rockwell Medical Inc , Home Infusion Program , Baxter Healthcare Corporation , Rockwell Medical Technologies Inc , National Home Infusion Association , Nasdaq , Product Development , View Research , Ministry Of Food , Jeil Pharmaceutical Co Ltd , Supplemental Data , Infusion Trial , Rockwell Medical , Ferric Pyrophosphate Citrate , Home Infusion , Chief Executive Officer , Infusion Program , Grand View , Drug Safety , Triferic Dialysate , Triferic Injection , Wanbang Biopharmaceuticals , Operating Results Conference Call , Annual Report , Use Assets , Term Liability , Stockholder Equity , Consolidated Statements , Except Shares , Per Share Amounts , Diluted Net Loss , Diluted Weighted Average Shares , Medical Technologies , Rockwell Medical Technologies , Nc ,